ADR120S, Inc. (TYO:3750)

Japan flag Japan · Delayed Price · Currency is JPY
869.00
+1.00 (0.12%)
At close: Feb 6, 2026
-2.80%
Market Cap7.76B -2.0%
Revenue (ttm)49.00M -93.8%
Net Income-1.84B
EPS-205.98
Shares Out8.93M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,600
Average Volume1,825
Open868.00
Previous Close868.00
Day's Range868.00 - 873.00
52-Week Range642.00 - 990.00
Beta0.14
RSI60.55
Earnings DateFeb 13, 2026

About ADR120S

ADR120S, Inc. engages in the research, development, production, and sale of cell therapy related medical devices in Japan. The company sells cell therapy kits, as well as engages in the research and development of cell therapy technology, etc. Its products pipeline includes ECCI-50 for the treatment of male stress urinary incontinence; ECCL-50 to treat liver cirrhosis; and Cyt-006 to prevent postoperative adhesion for primary rectal cancer. The company is also conducting clinical trials/research on cell therapy for a range of diseases and appli... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 10
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 3750
Full Company Profile

Financial Performance

Financial Statements